A groundbreaking and fast-paced effort – combining biologic, clinical and regulatory expertise at the University of Colorado Anschutz – has helped propel an ambitious nationwide attempt to reverse osteoarthritis (OA), a painful degenerative disease that affects 32 million Americans.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
